secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-TECHNE Corp (TECH)
CIK:        0000842023
Form:       8-K
Filed at:   2026-09-23T21:08:31+00:00
Accession:  0001140361-26-037450
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Techne shareholders approve Merck KGaA acquisition; HSR waiting period expired
--------------------------------------------------------------------------------

- Merger Agreement approved: 121,929,544 for, 1,208,817 against, 30,610 abstaining.
- Non-binding advisory compensation vote failed: 25,912,275 for, 96,412,306 against.
- HSR waiting period expired Sept 18, 2026; closing expected late 2026/early 2027.
- CEO Kim Kelderman cites 'strong support' and near-term cash value for shareholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/842023/000114036126037450/0001140361-26-037450-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/842023/000114036126037450/ef20082601_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-037450

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer